{
    "code": "20000027",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=20000027",
    "time": "2019-05-31 03:05:38",
    "許可證字號": "衛署罕藥輸字第000027號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/02\/04",
    "發證日期": "102\/02\/04",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA02000002702",
    "中文品名": "止蹈錠12.5毫克",
    "英文品名": "Xenazine 12.5mg",
    "適應症": "治療亨汀頓舞蹈症之舞蹈症狀。",
    "劑型": "110錠劑",
    "包裝": "2-1000錠PE塑膠瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "Tetrabenazine"
    ],
    "限制項目": "02輸　入 1D須執行風險管理計畫 1EPhase IV Study",
    "申請商名稱": "620102W395  吉泰藥品股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "FFR0041100  RECIPHARM FONTAINE SAS",
        "製造廠廠址": "RUE DES PRES POTETS 21121 FONTAINE LES DIJON FRANCE",
        "製造廠公司地址": "28, BOULEVARD CLEMENCEAU, 21000 DIJON, FRANCE"
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FIE0115000  Bausch Health Ireland Limited",
            "製造廠廠址": "3013 Lake Drive, Citywest Business Campus, Dublin 24, Ireland",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200039800",
            "成分名稱": "Tetrabenazine",
            "含量描述": "",
            "含量": "12.5000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Agrylin PI_仿單-修改賦形劑-20150421-104-08-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=20000027&Seq=003&Type=9"
        },
        {
            "title": "12.5MG 瓶標-原廠提供104.12.23-104-12-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=20000027&Seq=001&Type=8"
        }
    ]
}